OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE is a French company
founded 24 years ago,
specialized in the sector Autres activités de soutien aux entreprises n.c.a..
Based in SAINTE-HERMINE (85210),
this company of category PME
shows in 2024 a revenue of 830 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE (SIREN 439330515)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
829 603 €
939 113 €
1 111 727 €
1 131 330 €
1 160 039 €
894 516 €
792 160 €
696 950 €
696 143 €
Net income
196 206 €
389 733 €
398 553 €
425 593 €
408 048 €
351 146 €
335 539 €
302 845 €
306 831 €
EBITDA
248 524 €
513 597 €
527 467 €
574 451 €
561 335 €
482 602 €
462 385 €
442 544 €
447 469 €
Net margin
23.7%
41.5%
35.8%
37.6%
35.2%
39.3%
42.4%
43.5%
44.1%
Revenue and income statement
In 2024, OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE achieves revenue of 830 k€. Revenue is growing positively over 9 years (CAGR: +2.2%). Significant drop of -12% vs 2023. After deducting consumption (8 k€), gross margin stands at 822 k€, i.e. a rate of 99%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 249 k€, representing 30.0% of revenue. Warning negative scissor effect: despite revenue change (-12%), EBITDA varies by -52%, reducing margin by 24.7 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 196 k€, i.e. 23.7% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
829 603 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
821 639 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
248 524 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
248 447 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
196 206 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
30.0%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 23.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.0%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.236%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
23.645%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
0.02
0.02
0.019
0.0
0.0
0.0
0.0
0.0
0.0
Financial autonomy
86.017
85.052
77.212
69.841
73.818
75.634
76.968
74.648
63.236
Repayment capacity
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Cash flow / Revenue
43.988%
43.654%
42.558%
39.451%
35.326%
37.718%
35.834%
41.5%
23.645%
Sector positioning
Debt ratio
0.02024
2022
2023
2024
Q1: 0.0
Med: 5.61
Q3: 47.03
Excellent
In 2024, the debt ratio of OFFICE REGIONAL PHARMACEU... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
63.24%2024
2022
2023
2024
Q1: 6.21%
Med: 32.46%
Q3: 67.88%
Good
In 2024, the financial autonomy of OFFICE REGIONAL PHARMACEU... (63.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.0 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Excellent
In 2024, the repayment capacity of OFFICE REGIONAL PHARMACEU... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 270.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
270.69
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
710.755
666.129
437.259
330.863
379.159
409.904
434.179
394.443
270.69
Interest coverage
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.008
0.0
Sector positioning
Liquidity ratio
270.692024
2022
2023
2024
Q1: 120.11
Med: 218.14
Q3: 571.7
Good-16 pts over 3 years
In 2024, the liquidity ratio of OFFICE REGIONAL PHARMACEU... (270.69) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.0x2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.61x
Average
In 2024, the interest coverage of OFFICE REGIONAL PHARMACEU... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 154 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 87 days. The gap of 67 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 1 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 149 days of revenue, i.e. 342 k€ to permanently finance.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
342 361 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
154 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
87 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
1 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
149 j
WCR and payment terms evolution OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
306 219 €
307 236 €
244 009 €
270 180 €
216 939 €
334 127 €
338 966 €
257 063 €
342 361 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
1
Customer payment term (days)
144
167
155
171
115
148
139
141
154
Supplier payment term (days)
100
62
57
79
26
12
10
45
87
Positioning of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE in its sector
Comparison with sector Autres activités de soutien aux entreprises n.c.a.
Valuation estimate
Based on 131 transactions of similar company sales
(all years),
the value of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE is estimated at
821 494 €
(range 264 205€ - 1 587 525€).
With an EBITDA of 248 524€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.36x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
131 transactions
264k€821k€1587k€
821 494 €Range: 264 205€ - 1 587 525€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
248 524 €×4.8x
Estimation1 205 294 €
361 917€ - 2 073 472€
Revenue Multiple30%
829 603 €×0.36x
Estimation295 847 €
147 761€ - 559 204€
Net Income Multiple20%
196 206 €×3.3x
Estimation650 464 €
194 593€ - 1 915 139€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Autres activités de soutien aux entreprises n.c.a.)
Compare OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE with other companies in the same sector:
Frequently asked questions about OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE
What is the revenue of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE ?
The revenue of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE in 2024 is 830 k€.
Is OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE profitable?
Yes, OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE generated a net profit of 196 k€ in 2024.
Where is the headquarters of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE ?
The headquarters of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE is located in SAINTE-HERMINE (85210), in the department Vendee.
Where to find the tax return of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE ?
The tax return of OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE operate?
OFFICE REGIONAL PHARMACEUTIQUE D'INTERET ECONOMIQUE operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart